Kaori Suzuki
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Human cathelicidin peptide LL-37 induces endothelial-to-mesenchymal transition.
Journal: Bioscience, biotechnology, and biochemistry
Published: June 07, 2025
Lipopolysaccharides and Cellular Senescence: Involvement in Atherosclerosis.
Journal: International journal of molecular sciences
Published: August 17, 2022
Age‑related differences for expression of the nerve‑specific proteins after peripheral nerve injury.
Age‑related differences for expression of the nerve‑specific proteins after peripheral nerve injury.
Journal: Experimental and therapeutic medicine
Published: June 29, 2022
Human Cathelicidin Peptide LL-37 Induces Cell Death in Autophagy-Dysfunctional Endothelial Cells.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: January 19, 2021
Bacterial lipopolysaccharide and antimicrobial LL-37 enhance ICAM-1 expression and NF-κB p65 phosphorylation in senescent endothelial cells.
Journal: International journal of molecular medicine
Published: March 13, 2019
MrgX2‑mediated internalization of LL‑37 and degranulation of human LAD2 mast cells.
Journal: Molecular medicine reports
Published: June 16, 2018
Antimicrobial cathelicidin peptide LL-37 inhibits the pyroptosis of macrophages and improves the survival of polybacterial septic mice.
Journal: International immunology
Published: April 24, 2015
Dominant effects of first monolayer energetics at donor/acceptor interfaces on organic photovoltaics.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: February 16, 2015
Human Host Defense Cathelicidin Peptide LL-37 Enhances the Lipopolysaccharide Uptake by Liver Sinusoidal Endothelial Cells without Cell Activation.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: December 23, 2014
Last Updated: 09/26/2026